BLFS
Price
$22.10
Change
+$0.01 (+0.05%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
810.87M
77 days until earnings call
TCMD
Price
$9.79
Change
-$0.06 (-0.61%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
369.35M
81 days until earnings call
Interact to see
Advertisement

BLFS vs TCMD

Header iconBLFS vs TCMD Comparison
Open Charts BLFS vs TCMDBanner chart's image
BioLife Solutions
Price$22.10
Change+$0.01 (+0.05%)
Volume$5K
Capitalization810.87M
Tactile Systems Technology
Price$9.79
Change-$0.06 (-0.61%)
Volume$3.02K
Capitalization369.35M
BLFS vs TCMD Comparison Chart
Loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLFS vs. TCMD commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a StrongBuy and TCMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (BLFS: $22.09 vs. TCMD: $9.85)
Brand notoriety: BLFS and TCMD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BLFS: 73% vs. TCMD: 122%
Market capitalization -- BLFS: $810.87M vs. TCMD: $369.35M
BLFS [@Medical Specialties] is valued at $810.87M. TCMD’s [@Medical Specialties] market capitalization is $369.35M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 1 FA rating(s) are green whileTCMD’s FA Score has 1 green FA rating(s).

  • BLFS’s FA Score: 1 green, 4 red.
  • TCMD’s FA Score: 1 green, 4 red.
According to our system of comparison, both BLFS and TCMD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 4 TA indicator(s) are bullish while TCMD’s TA Score has 4 bullish TA indicator(s).

  • BLFS’s TA Score: 4 bullish, 6 bearish.
  • TCMD’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, TCMD is a better buy in the short-term than BLFS.

Price Growth

BLFS (@Medical Specialties) experienced а +0.18% price change this week, while TCMD (@Medical Specialties) price change was +2.82% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.26%. For the same industry, the average monthly price growth was +6.83%, and the average quarterly price growth was -0.38%.

Reported Earning Dates

BLFS is expected to report earnings on Aug 07, 2025.

TCMD is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Medical Specialties (+0.26% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLFS($811M) has a higher market cap than TCMD($369M). BLFS has higher P/E ratio than TCMD: BLFS (238.10) vs TCMD (12.72). BLFS YTD gains are higher at: -14.908 vs. TCMD (-42.499). TCMD has higher annual earnings (EBITDA): 24.5M vs. BLFS (-45.24M). TCMD has more cash in the bank: 75.2M vs. BLFS (51.7M). BLFS has less debt than TCMD: BLFS (42.7M) vs TCMD (50.4M). TCMD has higher revenues than BLFS: TCMD (274M) vs BLFS (143M).
BLFSTCMDBLFS / TCMD
Capitalization811M369M220%
EBITDA-45.24M24.5M-185%
Gain YTD-14.908-42.49935%
P/E Ratio238.1012.721,871%
Revenue143M274M52%
Total Cash51.7M75.2M69%
Total Debt42.7M50.4M85%
FUNDAMENTALS RATINGS
BLFS vs TCMD: Fundamental Ratings
BLFS
TCMD
OUTLOOK RATING
1..100
577
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
78100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6090
P/E GROWTH RATING
1..100
1516
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TCMD's Valuation (62) in the Medical Specialties industry is somewhat better than the same rating for BLFS (95). This means that TCMD’s stock grew somewhat faster than BLFS’s over the last 12 months.

BLFS's Profit vs Risk Rating (78) in the Medical Specialties industry is in the same range as TCMD (100). This means that BLFS’s stock grew similarly to TCMD’s over the last 12 months.

BLFS's SMR Rating (100) in the Medical Specialties industry is in the same range as TCMD (100). This means that BLFS’s stock grew similarly to TCMD’s over the last 12 months.

BLFS's Price Growth Rating (60) in the Medical Specialties industry is in the same range as TCMD (90). This means that BLFS’s stock grew similarly to TCMD’s over the last 12 months.

BLFS's P/E Growth Rating (15) in the Medical Specialties industry is in the same range as TCMD (16). This means that BLFS’s stock grew similarly to TCMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLFSTCMD
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 7 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 16 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSGSX15.03N/A
N/A
MassMutual Small Cap Gr Eq R5
AMRAX6.47N/A
N/A
American Growth One A
PMDDX18.13N/A
N/A
Principal Small-MidCap Dividend Inc C
MOWIX18.03N/A
N/A
Moerus Worldwide Value Institutional
JNGTX63.99-0.86
-1.33%
Janus Henderson Glb Tech and Innovt D

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with RGEN. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
-3.16%
RGEN - BLFS
55%
Loosely correlated
-5.78%
DHR - BLFS
48%
Loosely correlated
-5.54%
RVTY - BLFS
47%
Loosely correlated
-4.01%
TWST - BLFS
46%
Loosely correlated
-7.89%
GH - BLFS
46%
Loosely correlated
-7.21%
More

TCMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCMD has been loosely correlated with OFIX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if TCMD jumps, then OFIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCMD
1D Price
Change %
TCMD100%
-5.29%
OFIX - TCMD
52%
Loosely correlated
-4.00%
AXGN - TCMD
43%
Loosely correlated
-1.51%
AORT - TCMD
43%
Loosely correlated
-2.13%
BVS - TCMD
39%
Loosely correlated
-7.01%
BLFS - TCMD
37%
Loosely correlated
-3.16%
More